A carregar...
SM-01 APPLICATION OF BEVACIZUMAB TO POST-IRRADIATED CEREBRAL LESION: DIAGNOSIS, INTERVENTION AND OUTCOME
BACKGROUND: Taking results of AVAglio (Chinot et al., 2014), BRAIN study (Friedman et al., 2009) and JO22506 (Nagane et al., 2012), bevacizumab (BEV) had been approved for the treatment of newly diagnosed and recurrent malignant glioma. In addition, there are some trials using BEV for symptomatic ce...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218610/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou277.1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|